Transcatheter Tricuspid Valve Replacement: When Do Signals Become Evidence?
Canadian Journal of Cardiology · 2026-09 · 42 (9) · 1964-1966
DOI: 10.1016/j.cjca.2026.06.004 ↗Kurz gefasst
Editorial in der Zeitschrift Canadian Journal of Cardiology, 2026-09. Verfasst von Domenico Angellotti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, Bern, Switzerland; Department of Advanced Biomedical Sciences, University of Naples Federico II, …. Die Arbeit nennt 11 Literaturangaben. Gefördert von: Abbott Vascular.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Bern University Hospital, Bern, Switzerland; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
- Department of Cardiology, Bern University Hospital, Bern, Switzerland. Electronic address: Fabien.Praz@insel.ch.
Förderung
- Abbott Vascular
Zitieren
APA
Angellotti, D., & Praz, F. (2026). Transcatheter Tricuspid Valve Replacement: When Do Signals Become Evidence?. Canadian Journal of Cardiology, 42(9), 1964-1966. https://doi.org/10.1016/j.cjca.2026.06.004
Vancouver
Angellotti D, Praz F. Transcatheter Tricuspid Valve Replacement: When Do Signals Become Evidence?. Canadian Journal of Cardiology. 2026;42(9):1964-1966. doi:10.1016/j.cjca.2026.06.004
BibTeX
@article{Angellotti2026,
author = {Angellotti, Domenico and Praz, Fabien},
title = {Transcatheter Tricuspid Valve Replacement: When Do Signals Become Evidence?},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {9},
pages = {1964--1966},
doi = {10.1016/j.cjca.2026.06.004}
}
EUVIMED